Shijiazhuang Xingze Pharmaceutical Technology

Shijiazhuang Xingze Pharmaceutical Technology Co., Ltd. is a pharmaceutical research and development company headquartered in Shijiazhuang, Hebei Province, China. Established in 2019, the company focuses on the development of small molecule therapeutics, with a particular emphasis on nervous system diseases and endocrinology and metabolic disorders. Its primary product in development is a Magnesium Sulfate Oral Solution, which has reached the clinical stage with bioequivalence studies conducted in healthy subjects for indications such as constipation and bowel cleansing. The company is officially recognized as a science and technology small and medium-sized enterprise (SME) within the Shijiazhuang High-tech Industrial Development Zone. Shijiazhuang Xingze provides a range of services including pharmaceutical technology R&D, technical consulting, and technology transfer.